Premier Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Net Income	-0.37	-0.4	-3.76	-1.77	-2.6
Depreciation & Amortization	0	0	0	0	0
Other Amortization	0.32	0.37	0.34	0.75	0.18
Stock-Based Compensation	-	0.3	0.78	0.11	1.85
Other Operating Activities	-0.35	-0.6	2.12	-0.03	0.02
Change in Accounts Receivable	0	-0	-0	-	-
Change in Inventory	0.01	-0.03	-0.08	-	-
Change in Accounts Payable	-0.07	-0.1	0.11	0.04	0.07
Change in Other Net Operating Assets	0.11	0.01	-0.02	0.41	0.02
Operating Cash Flow	-0.34	-0.44	-0.51	-0.48	-0.46
Capital Expenditures	-0	-0	-0	-0	-
Investing Cash Flow	-0	-0	-0	-0	-
Short-Term Debt Issued	0.33	0.3	0.3	0.42	0.4
Total Debt Issued	0.33	0.3	0.3	0.42	0.4
Short-Term Debt Repaid	-	-	-0.03	-0.09	-
Total Debt Repaid	-	-	-0.03	-0.09	-
Net Debt Issued (Repaid)	0.33	0.3	0.27	0.33	0.4
Issuance of Common Stock	-	0	0.3	0.15	0
Financing Cash Flow	0.33	0.45	0.57	0.47	0.4
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-
Net Cash Flow	-0.02	0	0.06	-0.01	-0.07
Free Cash Flow	-0.35	-0.45	-0.51	-0.49	-0.46
Free Cash Flow Margin	-2444.02%	-1123.02%	-1282.19%	-	-
Free Cash Flow Per Share	-0.01	-0.13	-0.26	-0.80	-3.70
Cash Interest Paid	0	0	0.01	0.01	-
Levered Free Cash Flow	-0.31	-0.63	2.12	0.06	0.65
Unlevered Free Cash Flow	-0.39	-0.74	2	-0.18	0.59
Change in Working Capital	0.05	-0.12	0.01	0.45	0.09

Updated May 15, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.